BioPharma CreditLSE:BPCR +0.63%49 Dividend Payout Ratio is 0.35 as of Dec. 2025, which is 56% below its 10-year median of 0.80. GuruFocus rates LSE:BPCR with a GF Score™ of 49/100 and a GF Value™ of $0.97 (Fairly Valued). The stock has 2 warning signs investors should review. Among 932 Asset Management companies, BioPharma Credit ranks better than 55.47% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. BioPharma Credit's Dividend Payout Ratio for the
months ended in Dec. 2025 was 0.35.
The historical rank and industry rank for BioPharma Credit's Dividend Payout Ratio or its related term are showing as below:
LSE:BPCR'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.52 Med: 0.8 Max: 1.13
Current: 0.62
During the past 9 years, the highest Dividend Payout Ratio of BioPharma Credit was 1.13. The lowest was 0.52. And the median was 0.80.
LSE:BPCR's Dividend Payout Ratio is ranked better than 55.47% of 932
companies
in the Asset Management industry
Industry Median: 0.7
vs LSE:BPCR: 0.62
During the past 9 years, the highest 3-Year average Dividends Per Share Growth Rate of BioPharma Credit was 6.50% per year. The lowest was 0.00% per year. And the median was 0.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
BioPharma Credit (LSE:BPCR) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
BioPharma Credit Dividend Payout Ratio Related Terms
BioPharma Credit Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for BioPharma Credit's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:BPCR vs BLK, BX, KKR: Dividend Payout Ratio Comparison
For the Asset Management subindustry, BioPharma Credit's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioPharma Credit Dividend Payout Ratio vs Asset Management Industry
For the Asset Management industry and Financial Services sector, BioPharma Credit's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where BioPharma Credit's Dividend Payout Ratio falls into.
BioPharma Credit Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
BioPharma Credit's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioPharma Credit (LSE:BPCR) has a Dividend Payout Ratio of 0.35 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on BioPharma Credit and its competitors. This is 56% below median its historical median of 0.80. Over the past decade, BioPharma Credit's Dividend Payout Ratio has ranged from 0.52 to 1.13. According to the industry distribution chart, BioPharma Credit ranks #415 out of 932 companies in the Asset Management industry, placing it in the top 44.5%.
Is BioPharma Credit's Dividend Payout Ratio too high?
BioPharma Credit's current Dividend Payout Ratio of 0.35 is 56% below median its 10-year median of 0.80. Over the past 10 years, this metric has ranged from a low of 0.52 to a high of 1.13. The Asset Management industry median Dividend Payout Ratio is 0.70. BioPharma Credit's value of 0.35 is 50% below this industry median. Based on the distribution chart, BioPharma Credit ranks #415 out of 932 companies in the Asset Management industry, which is above the industry midpoint. Overall, BioPharma Credit has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BioPharma Credit's Dividend Payout Ratio compare to BLK and BX?
According to the Asset Management industry distribution chart, BioPharma Credit ranks #415 out of 932 companies for Dividend Payout Ratio. This puts BioPharma Credit in the upper half of its industry. The industry median Dividend Payout Ratio is 0.70. BioPharma Credit's value of 0.35 is 50% below this benchmark. Historically, BioPharma Credit's own Dividend Payout Ratio has ranged from 0.52 to 1.13 over the past decade. While the company's 10-year median is 0.80 vs. the industry median of 0.70, BioPharma Credit has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for an Asset Management company?
The median Dividend Payout Ratio among Asset Management companies is 0.70, based on 932 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioPharma Credit's current Dividend Payout Ratio of 0.35 is 50% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on BioPharma Credit and its competitors. For the Asset Management industry, the median Dividend Payout Ratio is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioPharma Credit's current Dividend Payout Ratio is 0.35, which is 56% below median its own 10-year median of 0.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioPharma Credit stock overvalued right now?
Based on GuruFocus' analysis, BioPharma Credit (LSE:BPCR) is currently considered Fairly Valued. The stock's GF Value™ is $0.97, compared to a current price of $0.96 — trading 1% below its estimated fair value. The current Dividend Payout Ratio is 0.35, which is 56% below median its 10-year median of 0.80 and 50% below the Asset Management industry median of 0.70. BioPharma Credit's overall GF Score™ is 49/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For BioPharma Credit (LSE:BPCR), the current Dividend Payout Ratio is 0.35 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioPharma Credit (LSE:BPCR) Overvalued in 2026?
Based on GuruFocus' analysis, BioPharma Credit stock appears to be undervalued.
The current stock price of $0.96 is trading 1% below its estimated GF Value™ of $0.97.
GuruFocus considers BioPharma Credit to be Fairly Valued.
Key valuation signals for LSE:BPCR:
Dividend Payout Ratio: 0.35 (56% below median its 10-year median of 0.80)
GF Value™: $0.97 vs. price of $0.96 (1% below fair value)
Industry Position: 50% below the Asset Management median (#415 of 932)
No single metric tells the full story. See the LSE:BPCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioPharma Credit PLC is an investment trust. Its investment objective is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The trust focuses on achieving its investment objective through direct or indirect exposure to debt assets, which include royalty investments, senior secured debt, unsecured debt, and credit linked notes. Its diversified investment portfolio is mainly secured by approved life sciences products and the cash flows derived from their sales.
49GF Score
Get the complete analysis for LSE:BPCR
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:BPCR has been successfully added to your 
